BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 901452)

  • 1. N delta-(phosphonacetyl)-L-ornithine, a potent transition state analogue inhibitor of ornithine carbamoyltransferase.
    Mori M; Aoyagi K; Tatibana M; Ishikawa T; Ishii H
    Biochem Biophys Res Commun; 1977 Jun; 76(3):900-4. PubMed ID: 901452
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and properties of delta-N-(phosphonacetyl)-L-ornithine. A transition-state analog inhibitor of ornithine transcarbamylase.
    Hoogenraad NJ
    Arch Biochem Biophys; 1978 May; 188(1):137-44. PubMed ID: 677887
    [No Abstract]   [Full Text] [Related]  

  • 3. The inactivation of ornithine transcarbamoylase by N delta-(N'-sulpho-diaminophosphinyl)-L-ornithine.
    Templeton MD; Mitchell RE; Sullivan PA; Shepherd MG
    Biochem J; 1985 Jun; 228(2):347-52. PubMed ID: 4015624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the L-ornithine transcarbamoylase from Pseudomonas savastanoi pv. phaseolicola that is resistant to the transition state analogue (R)-N delta-(N'-sulfodiaminophosphinyl)-L-ornithine.
    Templeton MD; Reinhardt LA; Collyer CA; Mitchell RE; Cleland WW
    Biochemistry; 2005 Mar; 44(11):4408-15. PubMed ID: 15766270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of porcine liver ornithine transcarbamylase.
    Koger JB; Howell RG; Kelly M; Jones EE
    Arch Biochem Biophys; 1994 Mar; 309(2):293-9. PubMed ID: 8135541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and equilibrium of the inactivation of ornithine transcarbamylases by pyridoxal 5'-phosphate.
    Marshall M; Cohen PP
    J Biol Chem; 1977 Jun; 252(12):4276-86. PubMed ID: 16927
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the transition-state analogue, delta-N-(phosphonacetyl)-L-ornithine on citrulline synthesis in isolated rat-liver mitochondria and on urea synthesis in isolated rat hepatocytes.
    Hoogenraad NJ; Sutherland TM; Howlett GJ
    Eur J Biochem; 1979 Oct; 100(1):309-15. PubMed ID: 488100
    [No Abstract]   [Full Text] [Related]  

  • 8. The illicit permeation of N-delta-phosphonoacetyl-L-ornithine under the form of a tripeptide. Selective inhibition in vivo of Escherichia coli L-ornithine carbamoyltransferase [proceedings].
    Penninckx M; Gigot D
    Arch Int Physiol Biochim; 1979 Feb; 87(1):198-9. PubMed ID: 92272
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitochondrial carbamyl phosphate and citrulline synthesis at high matrix acetylglutamate.
    Cohen NS; Cheung CW; Kyan FS; Jones EE; Raijman L
    J Biol Chem; 1982 Jun; 257(12):6898-907. PubMed ID: 7085611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a peptide form of N-delta-(phosphonoacetyl)-L-ornithine. Its antibacterial effect through the specific inhibition of Escherichia coli L-ornithine carbamoyltransferase.
    Penninckx M; Gigot D
    J Biol Chem; 1979 Jul; 254(14):6392-6. PubMed ID: 376531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inactivation of ornithine transcarbamoylase by Ndelta -(N'-Sulfodiaminophosphinyl)-L-ornithine, a true transition state analogue? Crystal structure and implications for catalytic mechanism.
    Langley DB; Templeton MD; Fields BA; Mitchell RE; Collyer CA
    J Biol Chem; 2000 Jun; 275(26):20012-9. PubMed ID: 10747936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An essential lysine in the substrate-binding site of ornithine carbamoyltransferase.
    Valentini G; De Gregorio A; Di Salvo C; Grimm R; Bellocco E; Cuzzocrea G; Iadarola P
    Eur J Biochem; 1996 Jul; 239(2):397-402. PubMed ID: 8706746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ornithine carbamoyltransferase deficiency. A new variant with subnormal enzyme activity.
    Rabier D; Benoit A; Petit F; Chekoury A; Bonnefont JP; Saudubray JM; Kamoun P
    Clin Chim Acta; 1989 Dec; 186(1):25-9. PubMed ID: 2612006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N5-phosphonoacetyl-L-ornithine (PALO): a convenient synthesis and investigation of influence on regulation of amino acid biosynthetic genes in Saccharomyces cerevisiae.
    Johnson B; Steadman R; Patefield KD; Bunker JJ; Atkin AL; Dussault P
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2351-3. PubMed ID: 21421312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of ornithine decarboxylase by beta,gamma unsaturated substrate analogs.
    Relyea N; Rando RR
    Biochem Biophys Res Commun; 1975 Nov; 67(1):392-8. PubMed ID: 1201030
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of carbamoylphosphate induced conformational changes upon binding to human ornithine carbamoyltransferase.
    De Gregorio A; Risitano A; Capo C; Criniò C; Petruzzelli R; Desideri A
    Biochem Mol Biol Int; 1999 Jun; 47(6):965-70. PubMed ID: 10410242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and interaction with Escherichia coli L-ornithine carbamolytransferase of two potential transition-state analogues.
    Penninckx M; Gigot D
    FEBS Lett; 1978 Apr; 88(1):94-6. PubMed ID: 346377
    [No Abstract]   [Full Text] [Related]  

  • 18. Phaseolotoxin-insensitive ornithine carbamoyltransferase of Pseudomonas syringae pv. phaseolicola: basis for immunity to phaseolotoxin.
    Staskawicz BJ; Panopoulos NJ; Hoogenraad NJ
    J Bacteriol; 1980 May; 142(2):720-3. PubMed ID: 7380807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of conformational flexibility in enzyme action-linkage between binding, isomerization, and catalysis.
    Goldsmith JO; Kuo LC
    J Biol Chem; 1993 Sep; 268(25):18481-4. PubMed ID: 8360150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dimethylnitrosamine upon carbamoyl phosphate and ornithine utilization in rat liver.
    Karsai T; Rády P; Nagy Z; Szondy Z
    Anticancer Res; 1985; 5(4):441-4. PubMed ID: 2864015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.